ArticleComputational and structural biotechnology journal2026
Structural evolution of polymorphic class I HLA alleles, designating HLA-C with uncertain assemblies.
Article in Computational and structural biotechnology journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hyper polymorphic major histocompatibility class I (MHC) molecules are key components for acquired immune responses. They have high specificity towards peptides presented to CD8 + T cells, resembling vaccine design and autoimmunity. However, a broader landscape over such a diverse set of evolutionary HLA molecules (in humans) and its structural variance in their crucial ectodomains or transmembrane regions remains elusive. Herein, we examined family-wide conserved HLA-A, HLA-B, and HLA-C alleles, and imputed structures over their full-length sequences. Despite high polymorphism among individual HLA molecules, the preserved amino acids remain proximal to C-terminus antigen binding sites. The HLA-A alleles with fewer evolutionary sub-branch have high affinity structures at both active (presenting peptides to T-cells) and inactive states of antigen cleft, compared to that of HLA-B and HLA-C. The cell-surface HLA molecules adopted better energy structures that are crucial for peptide binding and selectivity. HLA allelic families of HLA-A*02, HLA-B*57, and HLA-C*03 have shown well-defined novel secondary structures, compared to other variants. Particularly, the HLA-C alleles have structural deficiencies (insertions and sequence variability) within member-embedded domains, as well as lower internal contact energy compared to other class I HLAs. The neglected non-expressed alleles formed poor secondary structures, which reflect weaker potential to present peptides to T-cell receptors. Internal energies measured shall enable the quantification of the expressed or partially expressed HLA molecules over the cell surface. Comprehending such common structural assemblies of HLAs can guide the peptide-based vaccine development for patients with compromised immunity relating to antigen presentation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.